Department of Medical Sciences, Molecular Medicine

  Picture of Ann-Christine Syvanen
  (Foto: Jyrki Siikanen)
Prof. Ann-Christine Syvänen



Molecular Medicine
Department of Medical Sciences
Box 1432

See About Us for additional contact information.

Welcome to Molecular Medicine, Department of Medical Sciences

 (Enlarge in new window)

The research group in Molecular Medicine headed by Professor Ann-Christine Syvänen was started in 1998. The group studies human diseases using modern technology for genomics.

Professor Syvänen also heads the SNP&SEQ Technology Platform that offers genotyping and next generation sequencing services and training to academic researchers. The SNP&SEQ Technology Platform is part of the genomics platform of Science for Life Laboratory in Uppsala and is also funded by the Swedish Council for Research Infrastructures (VR-RFI).

Use the tab-menu above to view information about our research and services.



WGS and targetted sequencing in acute lymphoblastic leukemia identifies putative enhancer mutation associated with over-expression of a growth factor


A recent article by the Molecular Medicine group is highlighted by the journal Human Mutation.
Read the highlight feature
Read the article

The Molecular Medicine group receives funding for whole genome sequencing from SciLifeLab


The ALL project in the molecular medicine group has been granted funding from the Swedish Genomes Program at SciLifeLab, and will thereby receive support for whole genome sequencing of diagnostic, relapse and germline samples from ALL patients. Press release

VR grant to the Molecular Medicine group


Molecular Medicine research group has received funding from the Swedish Research Council for Medcine and Health (VR-MH) for the SLE research project.

New publication


A study describing allelic expression in different cell types is presented in Molecular Systems Biology by researchers from the Molecular Medicine group and the SNP&SEQ platform in collaboration with researchers from McGill University.

SciLifeLab receives funds for a new Illumina HiSeqXTen sequencing system


SciLifeLab is very excited to announce the receipt of a 200 million SEK gift from the Knut and Alice Wallenberg Foundation dedicated to expanding the genomics capacity in Sweden. These funds will partially be used for installing Illumina HiSeq XTen sequencers at the SNP&SEQ Technology Platform.

Publication in Science


A large-scale genomic study, published in Science today, suggests that it might be the genetic make-up that make crows choose partners that look alike. The sequencing of the crows was performed by SNP&SEQ using the HiSeq platform. Read the press release here.

New R&D manager at the SEQ-platform


Jessica Nordlund has joined the SNP&SEQ Technology Platform as manager for research and development.

Science for Life Laboratory joins the Illumina Genome Network


Illumina announced today that Science for Life Laboratory in Sweden has joined the Illumina Genome Network to provide researchers with broader access to Illumina’s whole genome sequencing technology. Read the press release here!